A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma
A Questionnaire Survey for Factors That Influence Postoperative Treatment Decision-making in Patients With Hepatocellular Carcinoma
1 other identifier
observational
2,500
1 country
1
Brief Summary
This is a non-interventional and questionnaire survey study. The investigators try to find out patient's willingness and expectation for post-operative treatments for hepatocellular carcinoma (HCC), as well as patients' willingness to participate in clinical trials using a questionnaire. The ultimate goal is to assist physicians in clinical treatment decision, clinical research, and government health and economic decision-making, as well as to help investigators understand how to increase public awareness of the HCC and the treatment course and efficacy of HCC, and the awareness of clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 21, 2020
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedJanuary 27, 2020
January 1, 2020
5 months
January 21, 2020
January 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
HCC patients' willingness and expectation for post-operative treatment.
Use questionnaires to understand the willingness and expectation of patients for post-operative treatment of hepatocellular carcinoma, as well as their willingness to participate in clinical trials.
6 months
Eligibility Criteria
Patients who have received surgical resection for hepatocellular carcinoma or their relatives
You may qualify if:
- Male or female aged 18 years or older;
- Confirmed diagnosis of HCC histologically or clinically;
- The participant must have received surgical resection;
- Ability to complete the questionnaire or independently or with the help of a friend, relative, or staff member of the oncology department.
You may not qualify if:
- The patients that researchers consider not suitable to participate in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Zhongshan Hospital
Shanghai, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Huichuan Sun
Shanghai Zhongshan Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
January 21, 2020
First Posted
January 27, 2020
Study Start
January 1, 2020
Primary Completion
June 1, 2020
Study Completion
July 1, 2020
Last Updated
January 27, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share